TLR7

Chr XXLRXLD

toll like receptor 7

Also known as: IMD74, SLEB17, TLR7-like

TLR7 encodes an endosomal receptor that recognizes single-stranded RNA from viruses and activates innate immune responses by triggering cytokine and interferon production. Mutations cause X-linked immunodeficiency with increased susceptibility to severe COVID-19 infections and X-linked systemic lupus erythematosus. The gene is highly constrained against loss-of-function mutations and shows both X-linked recessive and dominant inheritance patterns.

OMIMResearchSummary from RefSeq, OMIM, UniProt
XLR/XLDLOEUF 0.302 OMIM phenotypes
Clinical SummaryTLR7
🧬
Gene-Disease Validity (ClinGen)
systemic lupus erythematosus 17 · XLModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.98). One damaged copy is likely sufficient to cause disease.
💊
Clinical Trials
7 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.30LOEUF
pLI 0.979
Z-score 3.80
OE 0.10 (0.040.30)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
3.01Z-score
OE missense 0.56 (0.500.63)
205 obs / 367.6 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.10 (0.040.30)
00.351.4
Missense OE0.56 (0.500.63)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 2 / 20.7Missense obs/exp: 205 / 367.6Syn Z: -0.53

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TLR7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

RECRUITING
NCT07332481Phase PHASE3EMD Serono Research & Development Institute, Inc.Started 2026-03-10
EnpatoranPlaceboStandard of care (SoC)
Systematic Lupus ErythematosusCutaneous Lupus Erythematosus

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

RECRUITING
NCT07355218Phase PHASE3EMD Serono Research & Development Institute, Inc.Started 2026-04-01
EnpatoranPlaceboStandard of care (SoC)
Glioma

Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.

RECRUITING
NCT07077616Phase EARLY_PHASE1Biogenea Pharmaceuticals Ltd.Started 2025-07-01
Biological: personalized vaccine Based on genetic and transcriptional sequencing information, personalized peptide vaccines would be designed and produced;
Myeloproliferative DiseaseCOVID - 19

Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

ACTIVE NOT RECRUITING
NCT07204366Fondazione IRCCS Policlinico San Matteo di PaviaStarted 2022-05-06
Oral LeukoplakiaOral Leukoplakia of TongueOral Leukoplakia of Gingiva

Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore

RECRUITING
NCT03975322University of Erlangen-Nürnberg Medical SchoolStarted 2019-12-01
Chronic Spontaneous Urticaria (CSU)Hidradenitis Suppurativa (HS)Psoriasis (PsO)

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

RECRUITING
NCT07021495Leiden University Medical CenterStarted 2025-07-29
Cutaneous Lupus Erythematosus

Deep Phenotyping of Cutaneous Lupus Erythematosus

RECRUITING
NCT06411106Phase NACentre for Human Drug Research, NetherlandsStarted 2024-06
IMIQUIMOD cream 50mg/g
Clinical Literature
Open Research Assistant →